Elevate Uranium Financials
| ELVUF Stock | USD 0.20 0.01 5.26% |
With this module, you can analyze Elevate financials for your investing period. You should be able to track the changes in Elevate Uranium individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Elevate |
Understanding current and past Elevate Uranium Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Elevate Uranium's financial statements are interrelated, with each one affecting the others. For example, an increase in Elevate Uranium's assets may result in an increase in income on the income statement.
The data published in Elevate Uranium's official financial statements typically reflect Elevate Uranium's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Elevate Uranium's quantitative information. For example, before you start analyzing numbers published by Elevate accountants, it's essential to understand Elevate Uranium's liquidity, profitability, and earnings quality within the context of the Energy space in which it operates.
Elevate Uranium Stock Summary
Elevate Uranium competes with Isoenergy, Paladin Energy, F3 Uranium, EnCore Energy, and Purepoint Uranium. Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. Elevate Uranium Ltd was incorporated in 1978 and is headquartered in West Perth, Australia. Elevate Uranium operates under Uranium classification in the United States and is traded on OTC Exchange.| Instrument | USA OTC Stock View All |
| Exchange | OTCQX Exchange |
| Business Address | 5 Ord Street, |
| Sector | Energy |
| Industry | Uranium |
| Benchmark | Dow Jones Industrial |
| Website | www.elevateuranium.com.au |
| Phone | 61 8 6555 1816 |
| Currency | USD - US Dollar |
Elevate Uranium Key Financial Ratios
There are many critical financial ratios that Elevate Uranium's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Elevate Uranium reports annually and quarterly.| Return On Equity | -0.41 | |||
| Return On Asset | -0.24 | |||
| Beta | 1.02 |
Elevate Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elevate Uranium's current stock value. Our valuation model uses many indicators to compare Elevate Uranium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elevate Uranium competition to find correlations between indicators driving Elevate Uranium's intrinsic value. More Info.Elevate Uranium is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elevate Uranium's earnings, one of the primary drivers of an investment's value.Elevate Uranium Systematic Risk
Elevate Uranium's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Elevate Uranium volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Elevate Uranium correlated with the market. If Beta is less than 0 Elevate Uranium generally moves in the opposite direction as compared to the market. If Elevate Uranium Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Elevate Uranium is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Elevate Uranium is generally in the same direction as the market. If Beta > 1 Elevate Uranium moves generally in the same direction as, but more than the movement of the benchmark.
Elevate Uranium November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Elevate Uranium help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Elevate Uranium. We use our internally-developed statistical techniques to arrive at the intrinsic value of Elevate Uranium based on widely used predictive technical indicators. In general, we focus on analyzing Elevate OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Elevate Uranium's daily price indicators and compare them against related drivers.
| Downside Deviation | 10.01 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 47.86 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 11.54 |
Complementary Tools for Elevate OTC Stock analysis
When running Elevate Uranium's price analysis, check to measure Elevate Uranium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevate Uranium is operating at the current time. Most of Elevate Uranium's value examination focuses on studying past and present price action to predict the probability of Elevate Uranium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevate Uranium's price. Additionally, you may evaluate how the addition of Elevate Uranium to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |